You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2), look for clinical trials, and connect with others living with it — all in one place.
Open the full Acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) hub →Acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) is a rare condition. Also known as AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2). Tomeko brings together the specialists, research, clinical trials, treatments and community for Acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:402020 · ICD-10 C92.0 · GARD 0012759
Start by learning the basics from an authoritative source, find a specialist or center that sees Acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2), and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2), filtered to your area.
Tomeko shows live, recruiting studies for Acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) from ClinicalTrials.gov on the hub.